Drug Trial Radar · NCT07392736
A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.
Last checked: Nov 19, 2026Latest source record: Feb 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
228
Planned (sponsor's estimate)
Start
Oct 26, 2021
Primary completion
Nov 7, 2029
Study completion Nov 7, 2029
Sponsor
- Lead sponsor
- Advenchen Laboratories, LLCIndustry
- Sponsor type
- Industry
- First posted
- Feb 6, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Screening
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial is an open, non-randomized, phase I/IIa clinical trial, which will evaluate the preliminary effectiveness and safety of AL8326 tablets in patients with advanced solid tumors
Conditions
- Solid Tumor
Interventions
AL8326 tabletsDrug
Tablet: 10mg/tablet; administered orally once daily
ToripalimabDrug
240mg Injection solution:21-Day cycles
Primary outcomes
What the sponsor says the trial is designed to measure.
- The first part (Phase I): Phase II recommended dose (RP2D)Time frame: At the end of Cycle 1 (each cycle is 28 days)
- The second part (Phase IIa):Objective remission rate (ORR)Time frame: Every 2/3/4 cycles,up to 24 month(each cycle is 21 days)
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
National GCP Center for Anticancer Drugs,The Independent Ethics Committee
Beijing, Beijing Municipality, China · Recruiting
The Cancer Hospital of the Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China · Recruiting
Hunan Cancer Hospital
Hunan, Changsha, China · Recruiting
Fujian Cancer Hospital
Fuzhou, Fujian, China · Recruiting
Cancer Hospital of Shantou University Medical College
Shantou, Guangdong, China · Recruiting
Yuebei People's Hospital
Shaoguan, Guangdong, China · Recruiting
The First Affiliated Hospital of Guilin Medical Universty
Guilin, Guangxi, China · Recruiting
Liuzhou Workers' Hospital
Liuzhou, Guangxi, China · Recruiting
The People's Hospital of Guangxi Zhuang Autonomous Region
Nanning, Guangxi, China · Recruiting
Guangxi Medical University Cancer Hospital
Nanning, Guangxi, China · Recruiting
Henan Cancer Hospital
Zhengzhou, Henan, China · Recruiting
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China · Recruiting
The First Affiliated Hospital of Xi'an Jiaotong University
Xi’an, Shanxi, China · Recruiting
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China · Recruiting
SIR RUN RUN SHAW Hospital Zhejiang University School Of Medicine
Hangzhou, Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.